# The FDA Is Publishing Drug Rejection Letters. Pharma Says That Is Worse Than Silence. - Date: 2026-04-22 - Category: Biotech & Life Sciences FDA started publishing drug rejection letters last year. Reading them reveals an uncomfortable pattern: some expose serious trial flaws while others have large sections removed. Pharma companies argue selective exposure is worse than silence — and links it to workforce cuts. ---